Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
17.36
+0.70 (4.20%)
At close: Oct 15, 2025, 4:00 PM EDT
17.37
+0.01 (0.06%)
After-hours: Oct 15, 2025, 5:53 PM EDT

Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.84 billion. The enterprise value is $1.47 billion.

Market Cap1.84B
Enterprise Value 1.47B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date Nov 11, 2025
Ex-Dividend Date n/a

Share Statistics

Biohaven has 105.79 million shares outstanding. The number of shares has increased by 26.59% in one year.

Current Share Class 105.79M
Shares Outstanding 105.79M
Shares Change (YoY) +26.59%
Shares Change (QoQ) +0.42%
Owned by Insiders (%) 11.14%
Owned by Institutions (%) 78.09%
Float 88.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 74.81
PB Ratio 13.09
P/TBV Ratio 16.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.26.

Current Ratio 3.82
Quick Ratio 3.26
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -295.94% and return on invested capital (ROIC) is -201.13%.

Return on Equity (ROE) -295.94%
Return on Assets (ROA) -103.41%
Return on Invested Capital (ROIC) -201.13%
Return on Capital Employed (ROCE) -219.99%
Revenue Per Employee n/a
Profits Per Employee -$3.00M
Employee Count256
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Biohaven has paid $859,000 in taxes.

Income Tax 859,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.10% in the last 52 weeks. The beta is 3.45, so Biohaven's price volatility has been higher than the market average.

Beta (5Y) 3.45
52-Week Price Change -67.10%
50-Day Moving Average 15.05
200-Day Moving Average 22.19
Relative Strength Index (RSI) 60.98
Average Volume (20 Days) 2,564,656

Short Selling Information

The latest short interest is 10.95 million, so 10.35% of the outstanding shares have been sold short.

Short Interest 10.95M
Short Previous Month 10.65M
Short % of Shares Out 10.35%
Short % of Float 12.39%
Short Ratio (days to cover) 4.29

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -937.36M
Pretax Income -766.11M
Net Income -766.97M
EBITDA -928.68M
EBIT -937.36M
Earnings Per Share (EPS) -$7.65
Full Income Statement

Balance Sheet

The company has $404.98 million in cash and $34.49 million in debt, giving a net cash position of $370.49 million or $3.50 per share.

Cash & Cash Equivalents 404.98M
Total Debt 34.49M
Net Cash 370.49M
Net Cash Per Share $3.50
Equity (Book Value) 134.59M
Book Value Per Share 1.27
Working Capital 350.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$645.08 million and capital expenditures -$1.35 million, giving a free cash flow of -$646.43 million.

Operating Cash Flow -645.08M
Capital Expenditures -1.35M
Free Cash Flow -646.43M
FCF Per Share -$6.11
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.59%
Shareholder Yield -26.59%
Earnings Yield -41.69%
FCF Yield -35.14%
Dividend Details

Analyst Forecast

The average price target for Biohaven is $49.23, which is 183.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target $49.23
Price Target Difference 183.58%
Analyst Consensus Strong Buy
Analyst Count 14
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -35.14%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2